2011Journal of Bengbu Medical CollegeRequires access

Bioequivalence of granisetron HCl orally disintegrating tablet in Chinese healthy volunteers

Zhiwen Jiang

Open publisher page 0 citations

Abstract

Objective:To study the pharmacokinetics of granisetron HCl orally disintegrating tablet and compare its relative bioavailability with domestic granisetron tablet.Methods:Twenty healthy volunteers were administered a single oral dose of domestic granisetron HCl orally disintegrating tablet or tablet(reference)in a randomized crossover study,and their plasma drug concentration was determined by HPLC-fluoremetry.Results:The plasma concentration-time curve was fitted to one-compartment model.The pharmacokinetic parameters obtained were:Cmax=(7.2±3.4)μg/L,t1/2 =(4.2±1.8)h,tmax =(1.3±0.3)h,AUC0~24 h=(37.3±25.6)μg·h·L.No significant difference was found between the test and the reference groups.The relative bioavailability obtained was(97.9±19.2)%.Conclusions:The two preparations are bioequivalent.

About this research paper

What this paper is about

Objective:To study the pharmacokinetics of granisetron HCl orally disintegrating tablet and compare its relative bioavailability with domestic granisetron tablet.Methods:Twenty healthy volunteers were administered a single oral dose of domestic granisetron HCl orally disintegrating tablet or tablet(reference)in a randomized crossover study,and their plasma drug concentration was determined by HPLC-fluoremetry.Results:The plasma concentration-time curve was fitted to one-compartment model.The pharmacokinetic parameters obtained were:Cmax=(7.2±3.4)μg/L,t1/2 =(4.2±1.8)h,tmax =(1.3±0.3)h,AUC0~24 h=(37.3±25.6)μg·h·L.No significant difference was found between the test and the reference groups.The relative bioavailability obtained was(97.9±19.2)%.Conclusions:The two preparations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the pharmacokinetics of granisetron HCl orally disintegrating tablet and compare its relative bioavailability with domestic granisetron tablet.Methods:Twenty healthy volunteers were administered a single oral dose of domestic granisetron HCl orally disintegrating tablet or tablet(reference)in a randomized crossover study,and their plasma drug concentration was determined by HPLC-fluoremetry.Results:The plasma concentration-time curve was fitted to one-compartment model.The pharmacokinetic parameters obtained were:Cmax=(7.2±3.4)μg/L,t1/2 =(4.2±1.8)h,tmax =(1.3±0.3)h,AUC0~24 h=(37.3±25.6)μg·h·L.No significant difference was found between the test and the reference groups.The relative bioavailability obtained was(97.9±19.2)%.Conclusions:The two preparations are bioequivalent.

Key concepts: Bioequivalence, Granisetron, Medicine, Bioavailability, Pharmacokinetics, Cmax, Pharmacology, Crossover study

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of granisetron HCl orally disintegrating tablet in Chinese healthy volunteers — Research Paper | ScholarLens